Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. discloses Nav1.7 blockers

July 12, 2017

Unity Biotechnology patents Bcl-W, Bcl-XL and Bcl-2 inhibitors

July 12, 2017

Boehringer Ingelheim Pharma patents polypeptides targeting LRP5 and LRP6

July 11, 2017

Hangzhou Innogate Pharma presents novel CKD and/or HDAC inhibitors

July 10, 2017

Redx Pharma patents Bruton tyrosine kinase inhibitors

July 10, 2017

GlaxoSmithKline and Astex Therapeutics describe novel prostaglandin-D2 synthase inhibitors

July 10, 2017

Mission Therapeutics discloses novel ubiquitin carboxyl-terminal hydrolase 30 inhibitors

July 7, 2017

University of Queensland, IOCB present novel HGXPRT inhibitors

July 7, 2017

Padlock Therapeutics patents protein-arginine deiminase type-4 inhibitors

July 7, 2017

Wake Forest, University College Dublin identify new angiotensin (1-7) analogues

July 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...